A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

PHASE1SuspendedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Healthy Volunteer

Interventions

DRUG

ABBV-1088

Oral Capsule

DRUG

Placebo for ABBV-1088

Oral Capsule

DRUG

Itraconazole (ITZ)

Oral Capsule

Trial Locations (2)

Acpru /Id# 270552, Grayslake

CenExel ACT- Anaheim Clinical Trials /ID# 276423, Anaheim